Deborah E Briggs
Overview
Explore the profile of Deborah E Briggs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nadasdy Z, Howell D, Torok A, Nguyen T, Shen J, Briggs D, et al.
Sci Adv
. 2022 May;
8(18):eabm6081.
PMID: 35507662
The grid-like activity pattern of cells in the mammalian entorhinal cortex provides an internal reference frame for allocentric self-localization. The same neurons maintain robust phase couplings with local field oscillations....
2.
Liu R, Melanson M, Bendahan N, Briggs D, Taylor S, Lomax L
Can J Neurol Sci
. 2020 Dec;
48(5):737-739.
PMID: 33272347
No abstract available.
3.
Nadasdy Z, Nguyen T, Torok A, Shen J, Briggs D, Modur P, et al.
Proc Natl Acad Sci U S A
. 2017 Apr;
114(17):E3516-E3525.
PMID: 28396399
The spatially periodic activity of grid cells in the entorhinal cortex (EC) of the rodent, primate, and human provides a coordinate system that, together with the hippocampus, informs an individual...
4.
Briggs D, French J
Expert Rev Neurother
. 2009 Oct;
3(1):127-31.
PMID: 19810855
About 20-40% of patients with epilepsy will be refractory to medical treatment with antiepileptic drugs. It is unclear whether patients are already drug-resistant at the time of their initial presentation,...
5.
Briggs D, Lee C, Spiegel K, French J
Epilepsy Res
. 2008 Aug;
82(1):86-92.
PMID: 18752932
Purpose: To determine whether pregabalin reduces SGTC seizures in clinically refractory epilepsy. Methods: Design: Post hoc analysis performed on pooled data from three double-blind, placebo-controlled trials of similar design. Participants:...
6.
Briggs D, French J
Expert Opin Drug Saf
. 2004 Sep;
3(5):415-24.
PMID: 15335297
This review discusses the safety and tolerability of levetiracetam, as presented by the available literature, with attention paid to special populations. In Phase II/III trials, the adverse effects occurring more...